Viral Vector CDMO Comparison: AAV Capacity & Lead Times
A 2026 analyst comparison of viral vector and gene therapy CDMOs covering AAV manufacturing capacity, bioreactor scale up to 5,000L, regulatory track records, and 8 to 18 month lead times across Catalent, Lonza, and 10 other providers.